Cellyan Biotechnology Co., Ltd

FY: Mar 31 2026

FY: Mar 31 2026

FY: Mar 31 2025

FY: Mar 31 2025

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Registration statement for securities of certain foreign private issuers

Notice of Effectiveness

Registration statement for securities of certain foreign private issuers

Prospectus Supplement with Pricing Information

Certification of approval for listing and registration on a national securities exchange

Registration of Securities on Exchange

Notice of Effectiveness

Registration statement for securities of certain foreign private issuers (amendment)

Registration statement for securities of certain foreign private issuers (amendment)

Free Writing Prospectus

Registration statement for securities of certain foreign private issuers (amendment)

Registration statement for securities of certain foreign private issuers

CHAN Kam Leung

Wong Lap Sun

Wang Zifeng

Wu Jingyan

Liu Shu

Zhou Mike Yao

Liang Chenyu Andy

Wang Liying

Pacific Health Century International Group

Atlantic Health Century International Group

Wong Lap Sun

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

No description available

Draft registration statement (confidential submission) (amendment)

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

Draft registration statement (confidential submission) (amendment)

Letter from the SEC

No description available

Draft registration statement (confidential submission) (amendment)